We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$454M
AUM Growth
-$8.55M
Cap. Flow
+$5.97M
Cap. Flow %
1.32%
Top 10 Hldgs %
31.03%
Holding
429
New
29
Increased
50
Reduced
86
Closed
8
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
26
PayPal
PYPL
$45.9B
$5.2M 1.15%
44,940
+404
+0.9% +$53.8K
MO icon
27
Altria Group
MO
$115B
$4.75M 1.05%
90,922
-69
-0.1% -$3.52K
NVS icon
28
Novartis
NVS
$292B
$4.6M 1.01%
52,418
-2,542
-5% -$220K
GOOG icon
29
Alphabet (Google) Class C
GOOG
$4.19T
$4.47M 0.99%
32,020
+40
+0.1% +$5.44K
MKC icon
30
McCormick & Company Non-Voting
MKC
$14.9B
$4.39M 0.97%
43,980
-15
-0% -$1.47K
WY icon
31
Weyerhaeuser
WY
$17B
$4.25M 0.94%
111,995
-234
-0.2% -$9.28K
PM icon
32
Philip Morris
PM
$299B
$3.96M 0.87%
42,128
+104
+0.2% +$10.4K
ADP icon
33
Automatic Data Processing
ADP
$114B
$3.6M 0.79%
15,832
-314
-2% -$67.2K
RMD icon
34
ResMed
RMD
$34.7B
$3.55M 0.78%
14,633
-525
-3% -$127K
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.08T
$3.48M 0.77%
9,860
TD icon
36
Toronto Dominion Bank
TD
$199B
$3.46M 0.76%
43,504
SYBT icon
37
Stock Yards Bancorp
SYBT
$2.48B
$3.33M 0.73%
62,961
-8,610
-12% -$493K
KO icon
38
Coca-Cola
KO
$386B
$3.3M 0.73%
53,264
-750
-1% -$45.6K
SYK icon
39
Stryker
SYK
$127B
$3.27M 0.72%
12,225
-285
-2% -$73.8K
EW icon
40
Edwards Lifesciences
EW
$52B
$3.26M 0.72%
27,706
+74
+0.3% +$8.3K
EL icon
41
Estee Lauder
EL
$37.4B
$3.17M 0.7%
11,628
+5
+0% +$1.5K
HCI icon
42
HCI Group
HCI
$2.32B
$3.09M 0.68%
45,296
-7,979
-15% -$545K
HIFS icon
43
Hingham Institution for Saving
HIFS
$650M
$2.99M 0.66%
8,725
-487
-5% -$180K
OKTA icon
44
Okta
OKTA
$29.1B
$2.98M 0.66%
19,721
+6,022
+44% +$1.08M
ROP icon
45
Roper Technologies
ROP
$42.2B
$2.95M 0.65%
6,245
+49
+0.8% +$22K
TRP icon
46
TC Energy
TRP
$64.4B
$2.89M 0.64%
51,225
-100
-0.2% -$5.26K
SBCF icon
47
Seacoast Banking Corp of Florida
SBCF
$3.33B
$2.88M 0.63%
82,127
+47
+0.1% +$1.71K
NVO
48
Novo Nordisk
NVO
$202B
$2.72M 0.6%
49,000
-376
-0.8% -$19.3K
TFX icon
49
Teleflex
TFX
$5.92B
$2.49M 0.55%
7,030
-750
-10% -$247K
VRTX icon
50
Vertex Pharmaceuticals
VRTX
$137B
$2.49M 0.55%
9,530
+20
+0.2% +$4.75K

Similar funds

American Research & Management Company's Q1 2022 Portfolio in Review

As of Q1 2022, American Research & Management Company held 429 positions worth $454M, down 1.9% from $462M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

American Research & Management Company's Q1 2022 filing shows 29 new, 50 increased, 86 reduced and 8 closed positions. Its largest new stake was Old National Bancorp Series A Preferred Stock: 36,772 shares worth $980K. The largest sale was U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul, an estimated $1.57M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Healthcare.

  • American Research & Management Company's largest Q1 2022 buy was Old National Bancorp Series A Preferred Stock: 36,772 shares worth $980K.
  • American Research & Management Company added most to Okta in Q1 2022, an estimated $1.08M increase.
  • American Research & Management Company's biggest Q1 2022 reduction was iShares Gold Trust, cutting an estimated $1.03M.
  • American Research & Management Company fully exited U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul in Q1 2022, selling an estimated $1.57M.
  • American Research & Management Company's ten largest holdings make up 31% of its $454M portfolio in Q1 2022.
  • American Research & Management Company opened 29 new positions and closed 8 in Q1 2022.
  • American Research & Management Company's portfolio value fell 1.9% quarter-over-quarter to $454M.

Based on American Research & Management Company's 13F filing for Q1 2022, filed 21 Apr 2022.